Codexis, a biocatalyst research company, signs “multimillion” dollar deal with Merck
Codexis, a biocatalyst research company based in Redwood City, Ca., has signed a significant licensing deal with Merck & Co.
See the statement here. The terms weren’t disclosed, but the company tells VentureWire it is in the multimillions of dollars (sub required).
Next Story: Battery Ventures buys Quovadx for $136.7M
Previous Story: Samplify, an IP compression technology, raises $6.5M
Tags: co:Codexis, co:merck
VentureBeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, GamesBeat
- Anthony Ha, Assistant Editor, VentureBeat
- Camille Ricketts, Lead Writer, GreenBeat
- Paul Boutin, Writer, VentureBeat
- Kim-Mai Cutler, Writer, VentureBeat
- Matthaus Krzykowski, Mobile Consultant & Coordinator
VentureBeat Start-Up Index
An index of the hottest startups, measured by trends in their traffic, news coverage, buzz and funding.